爱华网2014年11月11日在伦敦举行新闻发布会宣布启动预算为2500万美元《因素转基因》国际性转基因生物与农药安全性实验研究项目。动物试验将于2015年开始，延续2-3年，在此期间将定期发表中间结果。该项研究将试验一种抗除草剂转基因玉米以及其容忍喷洒的现实水平的草甘膦除草剂，试验动物总量超过6000只老鼠。如果能够获得额外的资金，也将研究转基因大豆品种。该项试验包括的三个方面，将对至关重要的问题做出回答：转基因食品/或草甘膦残留，长期将对不同的器官系统是否毒性？转基因食品/或草甘膦残留，是否致癌？转基因食品/或草甘膦残留，是否减少生育能力或者造成生育畸形？草甘膦除草剂配方制剂是否比单一成分草甘膦更加毒性或更少毒性？该项试验将在俄罗斯与西欧保密的地点进行。参与项目的科学家来自“中性”背景，因为他们与生物技术产业或反转运动皆没有联系，这样的因素将增加实验结果的信誉。项目科学审查理事会来自美国、意大利与俄罗斯的三位科学家系各自领域令人尊敬的专家。项目需要近2500万美元资助已经/正在从全球筹集。研究项目不接受研发生产转基因作物和/或草甘膦产业的资金。接受所有其他来源的资金。研究资金提供者对该项研究的设计、结果或者发表论文也不能产生影响。
The World’s Largest Study on GMO and Pesticide Safety was launchedby Factor GMOin London, UK on Tuesday. FactorGMO’s preparatory phase started in early 2014. The full experimentwill begin in 2015 and will last 2-3 years, with interim resultsbeing published at regular intervals during that time. The studywill test a herbicide-tolerant GM maize and realistic levels of theglyphosate herbicide it is engineered to be grown with a total ofover 6000 rats. Factor GMO will study GM soybean varieties if extra funding is madeavailable. The three arms of the experiment will enable vital questions to beanswered, such as: Is the GM food (or its associated pesticide)toxic to organ systems over the long-term? Does the GM food (or itsassociated pesticide) cause cancer? Does the GM food (or itsassociated pesticide) reduce fertility or cause birth defects? Isthe mixture of chemicals present in ‘Roundup’ herbicide more orless toxic than its active ingredient glyphosate? The study willtake place at undisclosed locations in Russia and WesternEurope. The scientists involved in Factor GMO come from a ‘neutral’background, in that they have no connection to the biotech industryor the anti-GMO movement, a factor that will add credibility to theresults. The 3 scientists on the study review board from USA, Italyand Russia are internationally respected experts in theirfields. The close to $25 million in funding needed for this project hasbeen/is being sourced from around the world. Factor GMO will not accept funds from theindustry that manufactures GM crops and/or their associatedpesticides. Funding from all other sources will be accepted. Thefunders of Factor GMO will have no influence on the design,results, or publication of the study.
$ 25 Million GMO and Pesticide Safety Study Launched inLondon
预算近2500万美元国际性转基因生物/草甘膦除草剂安全性长期试验研究项目在伦敦宣布启动
转载、翻译者：陈一文（cheniwan@cei.gov.cn）
Posted, translated by Chen I-wan（cheniwan@cei.gov.cn）
《转基因技术与人类安全》研究专家、80年代两届全国青联委员
"GM technology & mankind safety" researchexpert
Former National Youth Federation Committee Member during80s
转载自：《因素转基因》项目网站（2014-11-11）：http://factorgmo.com/zh/
《可持续脉搏》网站：
http://sustainablepulse.com/2014/11/11/25-million-gmo-pesticide-safety-study-launched-london/#.VGKvyvQYBzU
PostedonNov11 2014 - 5:50pmbySustainablePulse
The World’s LargestStudy on GMO and Pesticide Safety was launched by Factor GMO inLondon, UK on Tuesday.
《因素转基因》组织者2014年11月11日在伦敦宣布启动世界最大规模对转基因及其相关草甘膦除草剂安全性的试验研究。
WHICH QUESTIONS DOES THISUS$25 MILLION STUDY AIM TO ANSWER?
该项2500万美元的试验研究将回答哪些问题？
The ‘Factor GMO’ studywill investigate the health effects of a genetically modified (GMO)crop that has been in our food and animal feed supplies for manyyears. It will answer the question: Is this GMO food and associatedpesticide safe for human health?
《因素转基因》将研究多年来存在于我们食品与动物饲料供应的转基因作物的健康影响。该项试验将回答：转基因食品及其关联农药对人类健康是否安全？
Farmers, retailers, governments, scientists and consumers have beeninvolved in a heated international debate since GM foods wereintroduced in 1994. However, there has never been a scientificstudy that is comprehensive enough to give them a clear answerregarding the safety for human health of any one GM food – untilnow.
农民、零售商、政府、科学家与消费者，自转基因食品1994年引入以来，陷入了激烈的国际性争论。然而，至今还没有进行一项足够综合性的科学性研究对转基因食品对于人类健康的安全性给一项出清楚的回答。
‘Factor GMO’ will also add valuable data of unprecedented power toenable regulators, governments and the general public of everycountry to answer the question: Is the GM food and associatedpesticide tested safe at real-world levels of consumption andexposure?
“因素转基因”将提供具有无先例说服力更多有价值资料，允许各国监管机构、政府与公众回答：转基因食品及其关联农药在世界食用与接触真实水平下实验的结果是否安全？
STUDYSUMMARY
试验研究概述
Factor GMO’s preparatoryphase started in early 2014. The full experiment will begin in 2015and will last 2-3 years, with interim results being published atregular intervals during that time.
《因素转基因》的准备阶段于2014年初开始。完全的动物试验将于2015年开始，延续2-3年，在此期间将定期发表中间结果。
The study will test aherbicide-tolerant GM maize and realistic levels of theglyphosate
herbicide it isengineered to be grown with a total of over 6000 rats.
该项研究将试验一种抗除草剂转基因玉米以及其容忍喷洒的现实水平的草甘膦除草剂，试验动物总量超过6000只老鼠。
Factor GMO will studyother GM Maize varieties and GM soybean varieties if extra fundingis made available.
如果能够获得额外的资金，《因素转基因》也将研究其他转基因玉米品种与转基因大豆品种。
WHERE WILL THESTUDY TAKE PLACE?
该项试验研究在哪里进行？
The study will takeplace at undisclosed locations in Russia and Western Europe. Theexact locations of the study must be kept secret for securityreasons as we want to avoid any outside interference that couldcompromise the day-to-day running of the experiments and/or thefinal results.
该项试验将在俄罗斯与西欧保密的地点进行。进行该项试验的确切地点为安全理由必须保密，因为我们必须避免可能影响该项研究日常运行试验和/或最后结果的任何外部干扰。
WHAT WILL THESTUDY CONSIST OF?
该项研究将包括什么？
Laboratory animals(rats) will be fed certain GM foods and pesticides according to aprotocol whose scale, rigour and range of measurements will meetand exceed current international standards for testing the toxicityof GM foods, pesticides, and other chemicals.
实验动物（老鼠）将依据试验规范喂养某些转基因食物与农药，试验规范的规模、严格性以及检测的范围将满足转基因食品、农药与其他化学品毒性的国际现行试验标准。
The experiment uses morerigorous approaches to investigate the fundamental question of thesafety of GM foods and pesticides than are currently required byregulators. It will provide sufficient data to say with confidencewhether the real world levels of consumption of the GM food orexposure to its associated pesticide are safe.
该项试验采用的方法，将比监管机构对转基因食品与农药安全性根本性问题进行研究要求的方法更严格。该项研究将提供充分的数据，令人信任的回答真实世界水平条件下食用转基因食品或接触其关联农药是否安全。
The three arms of theexperiment will enable vital questions to be answered, suchas:
该项试验包括的三个方面，将对至关重要的问题做出回答，如：
Is the GM food (or itsassociated pesticide) toxic to organ systems over thelong-term?
转基因食品（或者其关联农药）长期将对不同的器官系统是否毒性？
Does the GM food (or itsassociated pesticide) cause cancer?
转基因食品（或者其关联农药）是否致癌？
Does the GM food (or itsassociated pesticide) reduce fertility or cause birthdefects?
转基因食品（或者其关联农药）是否减少生育能力或者造成生育畸形？
Is the mixture ofchemicals present in ‘Roundup’ herbicide more or less toxic thanits active ingredient glyphosate?
草甘膦除草剂配方制剂中存在的化学品混合物是否比其活性成分草甘膦更加毒性或更少毒性？
SCIENTISTS
科学家
The scientists involvedin Factor GMO come from a ‘neutral’ background, in that they haveno connection to the biotech industry or the anti-GMO movement, afactor that will add credibility to the results.
参与《因素转基因》项目的科学家来自“中性”背景，因为他们与生物技术产业或反转运动皆没有联系，这样的因素将增加实验结果的信誉。
The 3 scientists on thestudy review board are internationally respected experts in theirfields:
《因素转基因》项目审查理事会的科学家是他们各自领域令人尊敬的专家。
INTERNATIONAL SCIENTISTS REVIEWBOARD
国际科学家审查理事会
Dr. Bruce Blumberg –University of California, Irvine (U.S.A)
布鲁斯•布隆伯格 -- 加州大学Irvine分校（美国）
Professor, Developmental& Cell Biology, School of Biological Sciences
教授，发育与细胞生物学，生物科学学院
Professor,Pharmaceutical Sciences
教授，医药科学
Professor, BiomedicalEngineering @ The Henry Samueli School of Engineering
教授，生物医药工程 @ Henry Samueli工程学院
PH.D., University ofCalifornia, Los Angeles
博士，加州大学，洛杉矶
布隆伯格对《因素转基因》项目的评论：
“The Factor GMO studyhas the potential to provide invaluable information on the healtheffects of a commercialized, herbicide-resistant GM food and itsassociated herbicide. The cultivation of herbicide resistant cropsis widespread in the US, and the use of the herbicides to whichthese crops are resistant has increased many-fold in the decadessince they were introduced. There is a notable lack of published,peer-reviewed data on their safety, as well as data on the safetyof the increased use of herbicides with which they are grown. TheFactor GMO study could be very useful in reducing the uncertaintyabout the safety of these products.”
“《因素转基因》研究有潜力对商业化的、抗除草剂转基因作物及其关联除草剂的健康影响提供有价值的信息。抗除草剂作物在美国广泛种植，用于这些农作物的除草剂自推出以来其使用量翻了许多倍。然而，对它们的安全性，以及种植过程中不断增加使用的除草剂的安全性，明显缺乏经同行审查公开发表的资料。《因素转基因》研究对于减少关于这些产品不确定性而言可以非常有用。”
The Blumberg laboratoryis broadly interested in the study of gene regulation andintercellular signaling during embryonic development andphysiology. Current research focuses on the role of nuclear hormonereceptors in development, physiology and disease. Particularinterests include patterning of the vertebrate nervous system, thedifferential effects of endocrine disrupting chemicals (EDCs) onlaboratory model organisms compared with humans, interactionsbetween xenobiotic metabolism, inflammation, and cancer, and therole of environmental endocrine disrupting chemicals on thedevelopment of obesity and diabetes.
布隆伯格实验室广阔感兴趣的是研究胚胎发育期间的基因调控和细胞间信号与生理机能。目前的研究聚焦于核激素受体在发展、生理学和疾病中的作用。特别的兴趣包括脊椎动物神经系统的模式，内分泌干扰化学品（EDC）对实验室模型生物与人类的差异性作用，异型生物质代谢、炎症和癌症之间的相互作用，环境性内分泌干扰化学品对于发展肥胖症与糖尿病的作用。
Dr. Blumberg’s researchinterests include molecular embryology, molecular biology,developmental biology, functional genomics, endocrinology,pharmacology and high-throughput screening.
布隆伯格博士研究的兴趣包括分子胚胎学、分子生物学、发育生物学、功能基因组学、内分泌学、药理学和大规模筛选。
Dr.Oxana O. Sinitsyna -Professor, Dr. Sc. in Medicine (Russia)
奥克斯安娜•O•塞尼茨亚娜博士，教授，医学科学博士（俄罗斯）
Deputy Director forScience at the Federal State Organization “A. N. Sysin ResearchInstitute of Human Ecology and Environmental Health” of theMinistry of Health of the Russian Federation, Moscow
副主任，联邦机构“A•N•塞幸人类生态与环境性健康研究所，俄罗斯联邦卫生部，莫斯科
Head of the Laboratoryof Ecologo-Hygienic Assessment and Prediction of Chemicals’Toxicity
负责人，生态卫生评估与化学品毒性预测实验室
Academician for theRussian Academy of Natural Sciences
院士，俄罗斯自然科学院
塞尼茨亚娜博士对《因素转基因》项目的评论
“The scale and format ofthis research project will allow us to create a really objectiveand comprehensive data set on the mechanics of the impacts of a GMOdiet on the health of living organisms over the long term. From ascientific point of view the ‘Factor GMO’ project is highlyambitious, which makes it very interesting, for both the public andfor the scientists involved.
“该项研究项目的规模与格式将允许我们对长期食用转基因饮食对于健康的影响创造真正客观和综合性的数据组。从科学观点，《因素转基因》项目雄心勃勃,这使得它对公众与参与其中的科学家非常有趣。
“The evaluation ofallergenic and immunotoxic effects are accompanied by thepossibility of evaluating general toxicity and carcinogeniclong-term effects (not just 90 days, but long-term over 2-3 years)of the use of appropriate GMO diets. In addition, there has neverbeen comprehensive research investigating the effects of a GM foodon reproductive function. The protocol of the ‘Factor GMO’ projectincludes the assessment of the impacts of a GM food on 5generations, not only 2, as is suggested in the OECD*recommendations. Due to the uniqueness of the project, it’s aspecial honour and responsibility for me to represent Russia on theFactor GMO review board. With my international colleagues, we willmake every effort to ensure a comprehensive research experimentwith an impeccable reputation.”
“对使用适当转基因饮食不仅评价过敏性与免疫毒性作用，而且同时评价一般毒性与致癌长期影响（不是仅进行90天，而是长期进行2-3年）。此外，对于转基因食品对于生殖功能从来没有进行过综合性的研究。《因素转基因》的试验协议包括对转基因食品对5代影响的评估，而不是仅仅对2代（世界经济合作组织推荐的期限）。由于该项目的独特性，非常荣幸让我责任重大代表俄罗斯参加《因素转基因》项目的审查理事会。与我的国际同事们一起，我们将做出一切努力确保这项综合性的研究实验具有无可挑剔的声誉。”
* The Organisation forEconomic Cooperation and Development, which sets protocols forindustry safety studies on chemicals.
Dr.Sinitsyna’s main areas of researchinclude:
塞尼茨亚纳博士d主要研究领域包括：
• Elaboration ofregional regulation systems for chemicals in the environmentalobjects based on the tolerable daily intake (TDI), taking intoaccount the effects of complex exposure and differences in toxicityin different ways and methods of intoxication;
•精细化环境性对象中化学品的区域监管系统，基于可容忍的日摄入量（TDI），充分考虑复杂接触与不同途径毒性的差别以及中毒的方法；
• Improvement ofcriteria and methods of studying the combined action of substancesat levels lower than the maximum allowable concentration(MAC);
• 改进对于低于最大允许浓度（MAC）水平的物质共同作用进行研究的标准和方法；
• Elaboration ofscientific foundations for fundamental and applied problems ofenvironmental health, in particular, water hygiene and sanitaryprotection of water bodies
• 环境健康基础性与应用问题，特别是饮水卫生以及水体卫生保护，科学基础的细化
• Elaboration ofprinciples, criteria and methods of sanitary-epidemiologicalassessment of substances' safety, water treatment and disinfectionmethods, including a new physicochemical technology of photodynamicwater disinfection method.
• 物质安全性、水处理与消毒方法的卫生-流行病学评估原则、标准与方法，包括一种新的光动力水消毒方法，的精细化。
Dr. Fiorella Belpoggi –on the Review Board as a Fellow of the Collegium Ramazzini(Italy)
法瑞拉•贝勒坡基博士 --作为Ramazzini执行管理委员会研究员参加审查理事会（意大利）
贝勒坡基博士对《因素转基因》项目的评论
“The concern overgenetically modified (GM) crops is largely due to the fact thatplant breeders can construct synthetic DNA sequences and insertthese into crop genomes, effectively adding new traits to theplant. This raises enormous possibilities for developing benignproducts, but equally it has the potential to create products withunwanted traits and side-effects. The animal feeding studiesperformed up to now to study GM-related risks for consumers vary intest diet, length, and type of animal used, making the resultsdifficult to compare and interpret. Most are too short to detectpotential long-term effects. The proposed integrated rat-feedingstudy will investigate a wide range of possible health effects inconsistent experimental conditions. The long-term study design willreveal any effects that take time to show up. The Factor GMO studycould provide the detailed data needed for a scientificevidenced-based risk assessment of possible human health hazardsfrom the GM crop and its associated pesticide.”
“对于转基因作物的担心很大程度上由于育种者可以构建人为的DNA顺序，将它们插入农作物基因组，对职务有效添加新的性状。这对开发良性产品提供了巨大的可能性，但是同时带来含有不需要性状与副作用产品的潜在状况。为消费者健康研究转基因相关风险到目前为止进行的动物喂养研究，在试验用的饮食、期限、以及使用的动物方面各有不同，使得结果难于比较与解释。对发现潜在长期影响而言大部分这样的研究期限太短。我们提议的集成老鼠喂养研究将在一致的实验条件下研究广泛范围可能的健康影响。这样的长期研究设计将解释需要一定期限才显示的任何作用。《因素转基因》研究将对转基因作物及其关联农药可能的人类健康影响提供科学性基于证据的风险评估详尽数据。”
Fiorella Belpoggi, PhD,FIATP, is the Director and Chief of Pathology of the Cesare MaltoniCancer Research Centre of the Ramazzini Institute (Bentivoglio,Italy), where she has been working since 1981. Since 2010 she isalso Director of the European Experimental Laboratory, where GLPstudies are performed. Her research interests include long-termstudies with particular regard to energy (fuels, gamma radiation,electromagnetic fields).
法瑞拉•贝勒坡基，博士，FIATP，担任Ramazzini研究所（Bentivoglio，意大利）CesareMaltoni癌症研究中心主任与病理学负责人，1981年以来她在此机构工作2010年以来，她还担任遵循“良好实验室操作”规范工作的欧洲实验性实验室主任。她的研究兴趣包括长期研究，特别与能源（燃料、伽马辐射、电磁场）领域的长期研究。
Dr.Belpoggi holds adegree in Biological Sciences from the University of Bologna, Italy(1975); she completed a three-year postgraduate training at theInstitute of Human Pathological Anatomy and Histology of theFaculty of Medicine of the University of Bologna, Italy (1976-1980)which qualified her to enter the Italian National Register ofDoctors in Biological Sciences. As a Visiting Scientist she alsocompleted post-doctoral studies on the classification of humanlymphomas/leukemias at the Pathology Institute of Kiel, Germany(1980), and on the relation between cervical cancer and papillomavirus in women at the International Agency for Research on Cancerin Lyon, France (1987). In 1992 she was nominated as a Fellow ofthe Collegium Ramazzini and currently serves as a member of theExecutive Council.
贝勒坡基博士拥有意大利Bologna大学的生物科学学位（1975）；她在意大利Bologna大学医学院完成了人类的病理解剖学和组织学方面三年研究生培训（1976-1980），使其获得进入生物科学意大利国家注册博士的资格。作物访问科学家，她在德国Kiel病理研究所完成了对于人体淋巴瘤/白血病分类的博士后研究（1980），以及在法国里昂国家癌症研究机构对妇女宫颈癌和乳头状瘤病毒的研究（1987）。1992年，她被提名担任Ramazzini执行管理委员会研究员，目前担任执行理事会成员。
Dr.Belpoggi has authoredmore than 100 publications and is a Professor of Industrial andEnvironmental Carcinogenesis at the University of Turin, Italy. Sherepresented the Ramazzini Institute on the Faculty Council ofVeterinary Sciences at the University of Padua, Italy and managesthe Institute’s institutional relationship with the U.S. NationalToxicology Program. Dr.Belpoggi was the 2007 recipient of theRamazzini Award, conferred each year by the Mayor of Carpi, Italyto scientists deemed by the Collegium Ramazzini to have madeoutstanding contributions to furthering the aims of BernardinoRamazzini in safeguarding public health. Dr.Belpoggi was selectedfor different honors in Italy in recognition for her work indefense of environmental and occupational health. She is a Fellowof the International Academy of Toxicologic Pathology.
贝勒坡基博士发表过100多篇著作，在意大利土林大学担任工业与环境性致癌作用教授。她在意大利Padua大学兽医科学学院委员会代表Ramazzini研究所，并且为该研究所与美国国家毒理学计划管理该研究所的机构间关系。贝勒坡基博士2007年获得Ramazzini奖。该奖每年由意大利Carpi市市长授予Ramazzini执行管理委员会认为对实现BernardinoRamazzini捍卫公共健康宗旨方面做出杰出贡献者。贝勒坡基博士在意大利被选择授予不同的荣誉，以承认她在捍卫环境性与职业健康方面杰出的工作。她亦是国际毒理学病理学学院的研究员。
THEORGANIZERS
组织者
The Russiannon-government organization National Association for Genetic Safety(NAGS) is the initiator and coordinator of the Factor GMOexperiment. However, NAGS has no involvement in designing thestudy, in the day-to-day running of the experiment, or in thegathering, interpretation, or publication of the scientificresults. These aspects have been and will continue to be decidedand controlled by the independent scientists.
俄罗斯非政府组织《基因安全全国协会》（NAGS）是《因素转基因》实验的发起者与协调者。然而，《基因安全全国协会》不涉及该项研究的设计、实验的日常运行、或科学性结果的收集、解释或发表论文。这些方面由并且继续由独立科学家决定与控制。
The neutral scientificreview board showed interest in the comprehensive study, after theidea for such a study was introduced online by NAGS. Following afull introduction by the members of the scientific review boardregarding their work experience and expertise, NAGS supported theidea of them taking full control of the Factor GMO scientificprocess.
俄罗斯《基因安全全国协会》在网络上介绍从事这样一项研究的想法后，中性的科学审查理事会对该项综合性研究表示了兴趣。科学理事会的成员全面介绍了他们的工作经验与专长后，俄罗斯《基因安全全国协会》支持由他们完全控制《因素转基因》科学国产的想法。
The evaluation ofcorrect protocols and the selection of scientists to work directlyon the experimental phase of the study is under the completecontrol of the neutral scientific review board. NAGS has not hadany involvement in this process.
对正确的试验研究协议进行评价，以及选择直接从事该项研究实验阶段工作的科学家，在中性的科学审查理事会完全控制下。俄罗斯《基因安全全国协会》不以任何方式涉入这个过程。
NAGS was formed in 2004as a non-governmental, non-profit organization based in Moscow,Russia. NAGS’s aim is to contribute the protection of biologicaland genetic safety of humankind and the environment, and to promotesustainable development.
俄罗斯《基因安全全国协会》2004年创立，是一家非政府、非盈利性组织，总部在俄罗斯莫斯科。《基因安全全国协会》的目的是对保护人类与环境生物性与基因安全，以及促进可持续发展做出贡献。
NAGS has always promotedthe idea of comprehensive safety studies on GMOs and theirassociated pesticides and has therefore taken on the role ofcoordinating the funding and security for the Factor GMOstudy.
俄罗斯《基因安全全国协会》一直促进对转基因及其关联农药进行综合性安全性研究，因而承担为《因素转基因》研究项目筹集资金和安全性的协调工作。
Elena Sharoykina,initiator of the project ‘Factor GMO’, director and co-founder ofNAGS:
伊莉娜•沙罗伊基娜，《因素转基因》项目发起人，俄罗斯《基因安全全国协会》主任余合作创立人
沙罗伊基娜对《因素转基因》项目的评论
Comprehensive scientificsafety studies on GMOs and their related pesticides are longoverdue. All previous studies caused controversy for variousreasons: choice of animal, insufficient statistics, duration oftests, research parameters, and researchers’ connections to theanti-GMO movement or the biotech industry. ‘Factor GMO’ is intendedto remedy the situation. The project organizers have considered allof the points of disagreement and distrust surrounding thissubject. Factor GMO has in its arsenal a scientific protocol drawnup with all the necessary standards, an international scientificteam of leading professionals with a neutral background,independent funding, and perhaps most importantly, fulltransparency. Food is the main source of energy for all livingbeings, and its safety is the key to their health and well-being,as well as to sustainable development. In order to preventirreversible consequences, humankind must ensure the total safetyof GM crops and their associated pesticides before they are plantedeven more widely.
“对转基因及其相关农药进行的综合性科学研究已经拖延太久。过去所有的研究由于不同的原因造成争议：动物的选择、不充分的统计数据、试验的期限、研究指标、以及参与的研究者与反转运动或者生物技术产业的关系。《因素转基因》旨在解决这些情况。项目的组织者考虑了围绕这个议题的所有否定意见与不信任。《因素转基因》项目具有符合所有必要标准的科学规范协议、具中性背景的领先专业人员组成的国际科学团队、独立的资金，以及可能最重要的，充分透明度。食物是所有人与动物能源的来源，其安全性是他们的健康与幸福及其可持续发展的关键。为了防止不可逆的后果，在更加广泛种植前，人类必须确保转基因作物及其关联农药完全的安全性。
FUNDING
资助来源
The funding process willbe totally transparent and a full list of funders will be providedat the start of the experimental phase in 2015. We will not waitfor the results to be published before publishing the full list offunders as many scientific studies do.
资助过程将完全透明，2015年开始实验阶段前景公布资助者的完全名单。公布资助者完全名单前，我们不会发表研究的结果，如同许多科学性研究做的那样。
Up to this stage privateindividuals from across Russia and the EU have put forward theirfunds to support the project (names to be disclosed next year). Wecannot disclose the exact amount of funds collected until now dueto contractual agreements with the funders, however we can say thata high % of the total needed has been secured, allowing us to startthe experimental phase in Spring 2015.
到目前阶段为止，俄罗斯与欧盟的一些私人已经提供他们的一些资金来支持这个项目（他们的名字明年公布）。由于与资助者之间的合约协议，我们现在不能泄露到目前为止获得的准确金额资助，然而，我们可以说我们已经落实了所需资金的很高百分百，允许我们2015年春天开始《因素转基因》项目的实验阶段。
The close to $25 millionin funding needed for this project has been/is being sourced fromaround the world.
该项目需要的接近2500万美元资助已经/正在从全球筹集。
Factor GMO will notaccept funds from the industry that manufactures GM crops and/ortheir associated pesticides. Funding from all other sources will beaccepted.
《因素转基因》研究不接受研发生产转基因作物和/或其关联农药产业的资金。接受所有其他来源的资金。
The funders of FactorGMO will have no influence on the design, results, or publicationof the study.
《因素转基因》研究资金提供者对该项研究的设计、结果或者发表论文也不能产生影响。
For details on the study please contact NAGS and visit the website:
关于《因素转基因》研究项目的细节，请联系俄罗斯《基因安全全国协会》与访问该项目的网站：
www.factorgmo.com
Nadya Novoselova (forRussian and English): novoselova@factorgmo.com Tel: +7 910 468-17-32
娜嘉•诺沃斯洛娃（俄文与英文）：novoselova@factorgmo.com Tel: +7 910468-17-32
Ivan Lambert (forEnglish first language): ivanlambert@factorgmo.com
伊万•兰伯特（英文）：ivanlambert@factorgmo.com
